5 Simple Statements About RU.521 Explained
Outcomes of a 2nd comparative study have been claimed by Flinn et al. This can be a section III randomized Intergroup demo evaluating FC program compared to FAMP alone in 278 sufferers receiving their 1st chemotherapy program for B-CLL. Dosages of FC timetable have been similar to the main study.Springer Character or its licensor (e.g. a Modern soc